A GHRH agonist studied for pulsatile pituitary growth hormone release.
TR8CE uses one simple standard: 0.1 mL of bacteriostatic water per mg. A 5 mg vial takes 0.5 mL of water for a clean 10 mg/mL solution. Larger vials scale the water up to fit the glass.
| Vial size | BAC water | Concentration | 1 mg draws to |
|---|---|---|---|
| 5 mg | 0.5 mL | 10 mg/mL | 10 units |
| 10 mg | 1 mL | 10 mg/mL | 10 units |
| 20 mg | 2 mL | 10 mg/mL | 10 units |
Units are shown for a U-100 insulin syringe. A common starting dose is 1 mg. At 10 mg/mL, that draws to 10 units on a U-100 insulin syringe.
Binds GHRH receptors on pituitary somatotroph cells to trigger a transient surge of growth hormone that mimics the body's natural pulsatile pattern.
Tesamorelin is commonly taken morning and evening.
Add 0.5 mL of bacteriostatic water to a 5 mg Tesamorelin vial for a 10 mg/mL solution.
A common Tesamorelin starting dose is 1 mg, which at 10 mg/mL draws to 10 units on a U-100 insulin syringe.
Draw bacteriostatic water into a syringe, inject it slowly down the inside glass of the Tesamorelin vial (not onto the powder), and swirl gently until clear. Store refrigerated and use within the common window.
Add 0.5 mL of bacteriostatic water to a 5 mg Tesamorelin vial for a 10 mg/mL solution. A 1 mg dose then draws to 10 units on a U-100 insulin syringe.
Add 1 mL of bacteriostatic water to a 10 mg Tesamorelin vial for a 10 mg/mL solution. A 1 mg dose then draws to 10 units on a U-100 insulin syringe.
Add 2 mL of bacteriostatic water to a 20 mg Tesamorelin vial for a 10 mg/mL solution. A 1 mg dose then draws to 10 units on a U-100 insulin syringe.